ArticleFrontiers in pharmacology2018

MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With

Rossella Salemi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.